Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BIOSANTE PHARM
(NQ:
BPAX
)
1.140
USD
-0.010 (-0.87%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
1.150
Bid (Size)
1.140 (5700)
Ask (Size)
1.150 (200)
Prev. Close
1.150
Today's Range
1.140 - 1.180
52wk Range
1.010 - 2.940
Shares Outstanding
24,422,240
Dividend Yield
N/A
Top News
More News
BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results
May 10, 2013
from
Business Wire News Releases
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger
May 08, 2013
BioSante Pharmaceuticals (NASDAQ: BPAX ) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that each company will hold a special meeting of its stockholders on Wednesday,...
Read More
category
Benzinga
,
BPAX
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
More News
Read More
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger
May 08, 2013
from
Business Wire News Releases
Huge Potential but Tough Entry for Female Sexual Dysfunction Drugs
May 07, 2013
category
APRI
,
BPAX
,
Featured
, and 2 more.
from
Bio-Wire.Com
Ceregene Reports Disappointing Top-Line Data From Parkinson's Disease Phase 2b Study
April 19, 2013
category
Contracts
,
Management
,
Benzinga
, and 5 more.
from
Latest Articles from Benzinga.com
Ceregene Reports Data From Parkinson's Disease Phase 2b Study
April 19, 2013
from
PR Newswire
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger Agreement
April 12, 2013
from
Business Wire News Releases
BioSante Pharma Sends Letter to Holders, Urges Vote for Proposed Deal with ANI Pharma
March 19, 2013
category
Benzinga
,
BPAX
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote “FOR” Proposed Merger with ANI Pharmaceuticals, Inc.
March 19, 2013
from
Business Wire News Releases
BioSante Pharmaceuticals Announces Adjournment of Its Stockholders Meeting Until April 12, 2013
March 15, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here